Objective: We undertook this study to determine the morbimortality in gastric surgery for gastric carcinoma.
Methods: We carried out a retrospective, observational study performed at the Gastroenterology Service of the General Hospital of Mexico City between January 2004 and October 2005. Variables included sex, age, diagnosis, surgery performed and trans- and postoperative complications.
Results: Clinical files of 2208 patients were reviewed: 36 (1.63%) cases with gastric carcinoma were found. Twenty patients fulfilled inclusion criteria; there were nine (45%) females and 11 (55%) males with a median age of 60.3 years. Radiological studies performed were upper gastrointestinal series, esophagogastroduodenoscopy, chest x-ray, and computed tomography (CT). Localization of the tumors was as follows: 15 in the antrum, three in the fundus and body and two in the body portion of the stomach. Clinical staging was T3 N0 M0. Surgical procedures were as follows: 11 partial gastrectomies and 4 gastrojejunostomies. In three cases, total gastrectomy was done and in two cases lymphatic biopsy was done. No mortality was reported. Morbidity was reported in one case (5%) with enterocutaneous fistula.
Conclusions: Surgery is the treatment for gastric carcinoma. Preoperative staging is done with CT and laparoscopy. There was no mortality in our study. Morbidity is similar to that reported by other hospitals.